The OMsignal wearable ECG system demonstrated signal quality comparable to standard Holter monitoring with an 84% vs. 93% accuracy rating (p = 0.06).
Does the OMsignal wearable ECG sensor system provide equivalent signal quality and R-R coverage compared to a standard 3-lead Holter in healthy individuals?
The OMsignal wearable ECG garment provides comparable signal quality and heart rate accuracy to a standard 3-lead Holter, demonstrating proof-of-concept for its use in long-term ambulatory rhythm monitoring.
Absolute Event Rate: 0% vs 0%
Diagnosis of arrhythmic disorders is challenging because of their short-lasting, intermittent character. Conventional technologies of noninvasive ambulatory rhythm monitoring are limited by modest sensitivity. We present a novel form of wearable electrocardiogram (ECG) sensors providing an alternative tool for long-term rhythm monitoring with the potential of increased sensitivity to detect intermittent or subclinical arrhythmia. The objective was to assess the signal quality and R-R coverage of a wearable ECG sensor system compared to a standard 3-lead Holter. In this phase-1 trial, healthy individuals underwent 24-h simultaneous rhythm monitoring using the OMsignal system together with a 3-lead Holter recording. The OMsignal system consists of a garment (bra or shirt) with integrated sensors recording a single-lead ECG and an acquisition module for data storage and processing. Head-to-head signal quality was assessed regarding adequate P-QRS-T distinction and was performed by three electrophysiologists blinded to the recording technology. The accuracy of signal coverage was assessed using Bland-Altman analysis. Fifteen individuals underwent simultaneous 24-h recording. Signal quality and accuracy of the OMgaments was equivalent to Holter-monitoring (84% vs. 93% electrophysiologists rating, p = 0.06). Signal coverage of R-R intervals showed a very close overlay between the OMsignal system and Holter signals, mean difference in heart rate of 2 ± 5 bpm. The noise level of OMgarments was comparable to Holter recording. OMgarments provide high signal quality for adequate rhythm analysis, representing a promising novel technology for long-term non-invasive ECG monitoring.
Steinberg et al. (Mon,) reported a other. The OMsignal wearable ECG system demonstrated signal quality comparable to standard Holter monitoring with an 84% vs. 93% accuracy rating (p = 0.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: